South Georgia Capital’s Bristol-Myers Squibb BMY Stock Holding History

South Georgia Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$47K	Hold	800	–	–	0.11%	48
2015 Q2	$53K	Hold	800	–	–	0.11%	65
2015 Q1	$52K	Hold	800	–	–	0.1%	76
2014 Q4	$47K	Hold	800	–	–	0.08%	88
2014 Q3	$41K	Hold	800	–	–	0.06%	87
2014 Q2	$39K	Hold	800	–	–	0.05%	94
2014 Q1	$42K	Hold	800	–	–	0.04%	97
2013 Q4	$43K	Buy	+800	New	+$40.8K	0.03%	115

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

South Georgia Capital's BMY Position: Q3 2015 in Review

South Georgia Capital held its Bristol-Myers Squibb (BMY) position steady in Q3 2015 at 800 shares worth $47K. The position accounts for 0.11% of the portfolio, ranked #48.

South Georgia Capital first reported a position in BMY in Q4 2013 and has held it in 8 quarters since. The position peaked at $53K in Q2 2015. 1,452 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

South Georgia Capital held 800 shares of Bristol-Myers Squibb worth $47K as of Q3 2015.
South Georgia Capital left its Bristol-Myers Squibb share count unchanged in Q3 2015.
Bristol-Myers Squibb made up 0.11% of South Georgia Capital's portfolio in Q3 2015, its #48 holding.
South Georgia Capital first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 8 quarters since.
South Georgia Capital's Bristol-Myers Squibb position peaked at $53K in Q2 2015.
1,452 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on South Georgia Capital's 13F filing for Q3 2015, filed 10 Nov 2015.